Drug Enforcement D-0549-2023

CGMP Deviations

Status

Ongoing

Classification

Class II

Report Date

May 3, 2023

Termination Date

Product Information

Product description
BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-511-52
Product quantity
6 bottles
Reason for recall
CGMP Deviations
Recall initiation reason
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
Nationwide with the United States

Location & Firm

Recalling firm
Northwind Pharmaceuticals LLC
Address
4838 Fletcher Ave Ste 1000, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0549-2023
Event ID
91944
Recall initiation date
March 16, 2023
Center classification date
April 26, 2023
Code info
Lot#: F117312201, Exp. Date 06/30/2024
More code info